The writer METTL3 and METTL14 were reported to promote tumorigenesis in hepatocellular carcinoma and acute myeloid leukemia (AML), but have the opposite effect in gastric cancer (18, 32). Here, METTL14 is linked to hepatocellular carcinoma.